AÂ revolutionary cancer drug developed in Auckland is set to begin clinical trials.
Tarloxotinib is designed to help patients with head and neck cancers for which New Zealand ranks as one of the highest in the world for cases.
Auckland City Hospital radiation oncologist Dr. Andrew Macann joined Mike Hosking.
LISTEN ABOVE
Take your Radio, Podcasts and Music with you
